Jacobs Levy Equity Management, Inc Cardiff Oncology, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $24.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 16, 2023
SELL
$1.38 - $2.18 $43,463 - $68,659
-31,495 Reduced 32.45%
65,558 $91,000
Q2 2023

Aug 14, 2023
BUY
$1.37 - $1.95 $76,139 - $108,373
55,576 Added 133.99%
97,053 $142,000
Q1 2023

May 15, 2023
BUY
$1.45 - $2.09 $60,141 - $86,686
41,477 New
41,477 $68,000

Others Institutions Holding CRDF

# of Institutions
90
Shares Held
12.3M
Call Options Held
813K
Put Options Held
91.1K
View Full List

About Cardiff Oncology, Inc.

CRDF Quotes by TradingView
  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $107M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email